tirzepatide release date Delivers in SURMOUNT-2 Tirzepatide

To view or add a comment, sign in New paper spotlight | Albuminuria vs proteinuria in paediatric CKD risk prediction In paediatric chronic kidney disease (CKD), uACR (urinary albumin-to-creatinine ratio) and uPCR (protein-to-creatinine ratio) are widely used for risk stratification, but how do they compare head-to-head in predicting progression

Medication Interaction Framework: What Providers Must Evaluate Healthcare providers assessing concurrent use must consider baseline glucose control, prednisone indication and expected duration, tirzepatide efficacy to date, and individual risk factors for steroid-induced hyperglycemia

This preferential visceral fat loss occurs because GLP-1 signaling enhances insulin sensitivity in liver and muscle tissue, reducing the metabolic drive to store excess energy as visceral fat

Compounded tirzepatide at Vesta is the same dual GLP-1/GIP receptor agonist, prescribed for medical weight loss with provider-led titration

Latest Wegovy Lawsuit Updates August 13, 2025 Recent JAMA research suggests a potential link between certain weight-loss medications including semaglutide and tirzepatide and rare optic nerve disorders such as NAION [5.]